Lower serum potassium associated with increased mortality in dialysis patients: A nationwide prospective observational cohort study in Korea

被引:36
作者
Lee, Sunhwa [1 ]
Kang, Eunjeong [1 ]
Yoo, Kyung Don [2 ]
Choi, Yunhee [3 ]
Kim, Dong Ki [1 ]
Joo, Kwon Wook [1 ]
Yang, Seung Hee [4 ]
Kim, Yong-Lim [5 ]
Kang, Shin-Wook [6 ]
Yang, Chul Woo [7 ]
Kim, Nam Ho [8 ]
Kim, Yon Su [1 ]
Lee, Hajeong [1 ,4 ]
机构
[1] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[2] Dongguk Univ, Dept Internal Med, Gyeongju Hosp, Gyeongju, South Korea
[3] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul, South Korea
[4] Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea
[5] Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea
[6] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[7] Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea
[8] Chonnam Natl Univ Hosp, Dept Internal Med, Gwangju, South Korea
来源
PLOS ONE | 2017年 / 12卷 / 03期
关键词
AMBULATORY PERITONEAL-DIALYSIS; RESIDUAL RENAL-FUNCTION; HEMODIALYSIS-PATIENTS; PRACTICE PATTERNS; HYPOKALEMIA; ATHEROSCLEROSIS; MALNUTRITION; INFLAMMATION; SUPPLEMENTATION; NONADHERENCE;
D O I
10.1371/journal.pone.0171842
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Abnormal serum potassium concentration has been suggested as a risk factor for mortality in patients undergoing dialysis patients. We investigated the impact of serum potassium levels on survival according to dialysis modality. Methods A nationwide, prospective, observational cohort study for end stage renal disease patients has been ongoing in Korea since August 2008. Our analysis included patients whose records contained data regarding serum potassium levels. The relationship between serum potassium and mortality was analyzed using competing risk regression. Results A total of 3,230 patients undergoing hemodialysis (HD, 64.3%) or peritoneal dialysis (PD, 35.7%) were included. The serum potassium level was significantly lower (P < 0.001) in PD (median, 4.5 mmol/L; interquartile range, 4.0-4.9 mmol/L) than in HD patients (median, 4.9 mmol/L; interquartile range, 4.5-5.4 mmol/L). During 4.4-1.7 years of follow-up, 751 patients (23.3%) died, mainly from cardiovascular events (n = 179) and infection (n = 120). In overall, lower serum potassium level less than 4.5 mmol/L was an independent risk factor for mortality after adjusting for age, comorbidities, and nutritional status (sub-distribution hazard ratio, 1.30; 95% confidence interval 1.10-1.53; P = 0.002). HD patients showed a U-shaped survival pattern, suggesting that both lower and higher potassium levels were deleterious, although insignificant. However, in PD patients, only lower serum potassium level (<4.5 mmol/L) was an independent predictor of mortality (sub-distribution hazard ratio, 1.35; 95% confidence interval 1.00-1.80; P = 0.048). Conclusion Lower serum potassium levels (<4.5 mmol/L) occur more commonly in PD than in HD patients. It represents an independent predictor of survival in overall dialysis, especially in PD patients. Therefore, management of dialysis patients should focus especially on reducing the risk of hypokalemia, not only that of hyperkalemia.
引用
收藏
页数:15
相关论文
共 51 条
  • [1] Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation
    Avram, MM
    Mittman, N
    Myint, MM
    Fein, P
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (06) : 1351 - 1357
  • [2] Bergstrom J, 1983, Kidney Int Suppl, V16, pS153
  • [3] The meaning of hypokalemia in heart failure
    Bielecka-Dabrowa, Agata
    Mikhailidis, Dimitri P.
    Jones, Linda
    Rysz, Jacek
    Aronow, Wilbert S.
    Banach, Maciej
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 158 (01) : 12 - 17
  • [4] Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
    Block, GA
    Klassen, PS
    Lazarus, JM
    Ofsthun, N
    Lowrie, EG
    Chertow, GM
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08): : 2208 - 2218
  • [5] DOES POTASSIUM SUPPLEMENTATION LOWER BLOOD-PRESSURE - A METAANALYSIS OF PUBLISHED TRIALS
    CAPPUCCIO, FP
    MACGREGOR, GA
    [J]. JOURNAL OF HYPERTENSION, 1991, 9 (05) : 465 - 473
  • [6] Chattopadhyay J, 2014, ADV PERIT DIAL, V30
  • [7] Oral potassium supplement use and outcomes in chronic heart failure: A propensity-matched study
    Ekundayo, O. James
    Adamopoulos, Chris
    Ahmed, Mustafa I.
    Pitt, Bertram
    Young, James B.
    Fleg, Jerome L.
    Love, Thomas E.
    Sui, Xuemei
    Perry, Gilbert J.
    Siscovick, David S.
    Bakris, George
    Ahmed, Ali
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 141 (02) : 167 - 174
  • [8] ELLIOTT P, 1988, BRIT MED J, V297, P319
  • [9] Left Ventricular Mass in Chronic Kidney Disease and ESRD
    Glassock, Richard J.
    Pecoits-Filho, Roberto
    Barberato, Silvio H.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 : S79 - S91
  • [10] GLUCOSE INTOLERANCE WITH HYPOKALEMIA - FAILURE OF SHORT-TERM POTASSIUM DEPLETION IN NORMAL SUBJECTS TO REPRODUCE GLUCOSE AND INSULIN ABNORMALITIES OF CLINICAL HYPOKALEMIA
    GORDEN, P
    [J]. DIABETES, 1973, 22 (07) : 544 - 551